|
SKIL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.515400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.390400E-01 |
| Normal-vs-Stage2 |
4.396200E-02 |
| Normal-vs-Stage3 |
1.968960E-01 |
| Normal-vs-Stage4 |
2.594600E-01 |
| Stage1-vs-Stage2 |
1.240240E-01 |
| Stage1-vs-Stage3 |
4.999400E-01 |
| Stage1-vs-Stage4 |
5.852000E-01 |
| Stage2-vs-Stage3 |
2.918200E-01 |
| Stage2-vs-Stage4 |
3.243400E-01 |
| Stage3-vs-Stage4 |
9.693800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.322800E-01 |
| Normal-vs-AfricanAmerican |
3.450400E-01 |
| Normal-vs-Asian |
1.589020E-01 |
| Caucasian-vs-AfricanAmerican |
8.344200E-02 |
| Caucasian-vs-Asian |
3.515400E-01 |
| AfricanAmerican-vs-Asian |
7.200000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.788140E-02 |
| Normal-vs-Female |
4.879600E-01 |
| Male-vs-Female |
1.915890E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.076400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.488300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.345650E-01 |
| Normal-vs-Age(81-100Yrs) |
9.395800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.029800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.095960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.841000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.660200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.045800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.223200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.007400E-01 |
| Classical-VS-Follicular |
2.32659999999107E-05 |
| Classical-VS-Other |
1.673750E-02 |
| Classical-VS-Normal |
8.601000E-01 |
| Tall-VS-Follicular |
8.930200E-02 |
| Tall-VS-Other |
2.454800E-01 |
| Tall-VS-Normal |
3.550600E-01 |
| Follicular-VS-Other |
8.144800E-01 |
| Follicular-VS-Normal |
1.616760E-03 |
| Other-VS-Normal |
9.363600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.223900E-03 |
| Normal-vs-N1 |
4.964200E-01 |
| N0-vs-N1 |
7.111500E-02 |
|
|
